In 1998, Hirota et al. discriminated leiomyosarcomas (LMSs) from gastrointestinal stromal tumors (GISTs) by describing that true LMSs are negative for CD117 (KIT) and CD 34 and positive for smooth muscle actin or desmin [2]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.